Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Transition products (Axitinib and Eltrombopag)

NHS England

This public procurement record has 4 releases in its history.

Award

04 Sep 2025 at 17:47

UK7 - Contract Details Notice
Award

30 Jul 2025 at 11:23

UK6 - Contract Award Notice
Tender

04 Jun 2025 at 15:34

UK4 - Tender Notice
Planning

01 May 2025 at 16:18

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The public procurement process focuses on the NHS National Framework for Transition products, specifically Axitinib and Eltrombopag, led by NHS England. The procurement covers pharmaceutical products and is centred in Leeds, United Kingdom. This process has progressed through various stages, namely planning, tender, and currently sits at the award and contract phase. Key dates include the contract signing on August 18, 2025, and the commencement of the framework agreement on October 1, 2025, with an initial duration until January 31, 2027, and the option to extend up to 48 months. The procurement method is an open procedure and was initially incorrectly advertised as an open framework but should have been a standalone framework supported by the Government Procurement Agreement (GPA).

This procurement offers substantial growth opportunities for businesses involved in pharmaceutical production and distribution. The framework involves significant suppliers like DR REDDY'S LABORATORIES, NOVARTIS, PFIZER, TEVA UK, and others, highlighting potential collaboration with both SMEs and large-scale companies. Businesses with expertise in delivering pharmaceutical goods and those capable of fulfilling NHS supply chain requirements would find this opportunity particularly advantageous. The structured framework agreement allows for competition reopening, presenting ongoing participation prospects for suitable companies. This tender underscores potential for market presence expansion and long-term engagement with the NHS, benefiting those in the pharmaceutical sector actively looking to augment their market footprint.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Transition products (Axitinib and Eltrombopag)

Notice Description

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

Lot Information

Lot 1

Renewal: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Planning Information

NHS England is seeking to engage with suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework. Please indicate which products your Company is planning to bring to market in your response.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-050bb9
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/054095-2025
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£80,909,200 £10M-£100M
Lots Value
£80,909,200 £10M-£100M
Awards Value
£52,385,000 £10M-£100M
Contracts Value
£52,385,000 £10M-£100M

Notice Dates

Publication Date
4 Sep 202511 months ago
Submission Deadline
4 Jul 2025Expired
Future Notice Date
28 May 2025Expired
Award Date
16 Jul 20251 years ago
Contract Period
1 Oct 2025 - 31 Jan 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

NHS England, Leeds

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
7
Supplier Names

DR REDDY'S LABORATORIES (UK) LIMITED

NOVARTIS PHARMACEUTICALS UK LIMITED

PERENNIAL PHARMA LTD

PFIZER LIMITED

TEVA UK LIMITED

THORNTON & ROSS LIMITED

WOCKHARDT UK LIMITED

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...